- Valbiotis announces positive preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.
- Valbiotis consolidates its development of innovative natural health solutions by integrating the exploration of microalgae produced in New Caledonia, through an exclusive agreement with ADECAL-Technopole and IFREMER.
- The SPI fund, operated on behalf of the State by Bpifrance, becomes METEX’s reference shareholder with 25.9% of its capital in order to support the emergence of a European leader in industrial biotechnology.
